NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
08/28/2018
Back to search
Official data from USPTO
SIGMA PHARMACEUTICALS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
SIGMA PHARMACEUTICALS
ST13
US500000077178489Class
35
Filing
77178489
Registration
3621388
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
35
Latest update
08/28/2018
Trademark type
Word
Nice classes
35
Filing date
05/11/2007
Registration date
05/19/2009
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/28/2018
Last transaction
08/28/2018
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
04/01/1992
First use in commerce
04/01/1992
Drawing code
4
Owner type
16
Owner location
North Liberty, IA
Examiner
DAHLING,KRISTIN M
Law office
M40
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
Sigma Pharmaceuticals, LLC
Sigma Pharmaceuticals, LLC
Representatives
ROBERT E. MARSH CORPORATE COUNSEL GROUP LLP
Technical classification
Nice Classes
Class 35
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
wholesale distributorship services in the fields of ophthalmic pharmaceuticals and ophthalmic products
Publications
History of USPTO decisions and trademark events.
35 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
08/28/2018
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
08/28/2018
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/28/2018
E89R
TEAS SECTION 8 & 9 RECEIVED
08/17/2018
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
05/19/2018
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
01/14/2015
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
01/14/2015
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/14/2015
E815
TEAS SECTION 8 & 15 RECEIVED
12/29/2014
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/29/2014
R.PR
REGISTERED-PRINCIPAL REGISTER
05/19/2009
PUBO
PUBLISHED FOR OPPOSITION
03/03/2009
NPUB
NOTICE OF PUBLICATION
02/11/2009
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
01/23/2009
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/21/2009
ACEC
AMENDMENT FROM APPLICANT ENTERED
12/18/2008
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/18/2008
ALIE
ASSIGNED TO LIE
12/09/2008
PAPER RECEIVED
12/05/2008
CNRT
NON-FINAL ACTION MAILED
06/06/2008
CNRT
NON-FINAL ACTION WRITTEN
06/05/2008
ACEC
AMENDMENT FROM APPLICANT ENTERED
06/03/2008
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/03/2008
ALIE
ASSIGNED TO LIE
06/03/2008
PAPER RECEIVED
06/02/2008
CNFR
FINAL REFUSAL MAILED
12/19/2007
CNFR
FINAL REFUSAL WRITTEN
12/18/2007
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/07/2007
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/07/2007
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/07/2007
CNRT
NON-FINAL ACTION MAILED
08/27/2007
CNRT
NON-FINAL ACTION WRITTEN
08/26/2007
DOCK
ASSIGNED TO EXAMINER
08/24/2007
NWAP
NEW APPLICATION ENTERED
05/16/2007
Continuous trademark protection
Get notified about every new filing that threatens SIGMA PHARMACEUTICALS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.